Icon Wealth Partners, LLC Biogen Inc. Transaction History

Icon Wealth Partners, LLC

$878 Million
Q3 2023

A detailed history of Icon Wealth Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Icon Wealth Partners, LLC holds 910 shares of BIIB stock, worth $144,426. This represents 0.03% of its overall portfolio holdings.

Number of Shares

910

Previous 927 1.83%

Holding current value

$144,426

Previous $264,000 11.74%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $4,306 - $4,860	-17 Reduced 1.83%	910 $233,000
Q2 2023 Aug 03, 2023	SELL	$275.25 - $318.06 $33,030 - $38,167	-120 Reduced 11.46%	927 $264,000
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $79,277 - $90,333	-309 Reduced 22.79%	1,047 $291,000
Q2 2022 Jul 19, 2022	SELL	$187.54 - $223.02 $59,825 - $71,143	-319 Reduced 19.04%	1,356 $277,000
Q1 2022 Apr 19, 2022	BUY	$193.77 - $244.14 $2,131 - $2,685	11 Added 0.66%	1,675 $353,000
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $21,496 - $27,625	-96 Reduced 5.45%	1,664 $399,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $65,936 - $85,988	-233 Reduced 11.69%	1,760 $498,000
Q2 2021 Jul 30, 2021	SELL	$259.0 - $414.71 $107,744 - $172,519	-416 Reduced 17.27%	1,993 $690,000
Q1 2021 Apr 26, 2021	BUY	$242.95 - $284.63 $90,134 - $105,597	371 Added 18.2%	2,409 $674,000
Q4 2020 Feb 08, 2021	BUY	$236.26 - $355.63 $39,691 - $59,745	168 Added 8.98%	2,038 $499,000
Q3 2020 Oct 22, 2020	BUY	$264.77 - $305.71 $71,223 - $82,235	269 Added 16.8%	1,870 $530,000
Q2 2020 Jul 14, 2020	SELL	$258.66 - $342.55 $56,905 - $75,361	-220 Reduced 12.08%	1,601 $428,000
Q1 2020 Apr 17, 2020	SELL	$268.85 - $341.04 $87,913 - $111,520	-327 Reduced 15.22%	1,821 $576,000
Q4 2019 Jan 29, 2020	SELL	$220.06 - $304.07 $6,601 - $9,122	-30 Reduced 1.38%	2,148 $637,000
Q3 2019 Oct 24, 2019	BUY	$217.44 - $243.88 $869 - $975	4 Added 0.18%	2,178 $507,000
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $137,056 - $151,075	625 Added 40.35%	2,174 $508,000
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $44,642 - $69,825	-206 Reduced 11.74%	1,549 $366,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $11,418 - $14,462	-41 Reduced 2.28%	1,755 $528,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $17,317 - $22,645	-59 Reduced 3.18%	1,796 $635,000
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $75,195 - $89,617	292 Added 18.68%	1,855 $538,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $2,601 - $3,679	10 Added 0.64%	1,563 $428,000
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $477,764 - $535,132	1,553	1,553 $495,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.

Account

Icon Wealth Partners, LLC Biogen Inc. Transaction History